Biosenta Inc. (CSE:ZRO)
Canada · Delayed Price · Currency is CAD 0.0750
+0.0200 (36.36%)
Aug 7, 2026, 5:32 PM EST
Biosenta Balance Sheet
Financials in millions CAD. Fiscal year is October - September.
Millions CAD. Fiscal year is Oct - Sep.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Cash & Equivalents | 0.01 | 0.03 | 0.01 | 0.01 | 0.03 | 0.11 |
Cash & Short-Term Investments | 0.01 | 0.03 | 0.01 | 0.01 | 0.03 | 0.11 |
Cash Growth | 146.17% | 210.61% | 44.98% | -78.42% | -75.63% | 152.51% |
Other Receivables | 0.01 | 0.01 | 0.05 | 0.02 | 0.15 | 0 |
Receivables | 0.01 | 0.01 | 0.05 | 0.02 | 0.15 | 0 |
Inventory | 0.04 | 0.04 | 0.04 | 0.04 | 0.05 | 0.08 |
Prepaid Expenses | - | - | 0.01 | 0.03 | 0.04 | 0.07 |
Total Current Assets | 0.06 | 0.07 | 0.1 | 0.09 | 0.26 | 0.26 |
Property, Plant & Equipment | 0.04 | 0.04 | 0.01 | 0.02 | - | - |
Other Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
Total Assets | 0.09 | 0.11 | 0.11 | 0.11 | 0.26 | 0.26 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Accounts Payable | 1.5 | 1.43 | 1.32 | 1.23 | 0.75 | 0.57 |
Accrued Expenses | 2.2 | 1.86 | 0.86 | 0.87 | 0.55 | 0.82 |
Short-Term Debt | 0.91 | 0.63 | 0.1 | 0.32 | 1.57 | 1.15 |
Current Portion of Long-Term Debt | 6.29 | 5.94 | - | - | - | - |
Other Current Liabilities | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 |
Total Current Liabilities | 11.16 | 10.11 | 2.53 | 2.67 | 3.13 | 2.8 |
Long-Term Debt | - | 0.06 | 5.46 | 5.3 | 0.06 | 0.06 |
Total Liabilities | 11.16 | 10.17 | 7.99 | 7.96 | 3.19 | 2.86 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Common Stock | 15.46 | 15.32 | 15 | 13.4 | 12.06 | 10.03 |
Retained Earnings | -26.5 | -25.54 | -23.45 | -21.22 | -14.92 | -13.46 |
Comprehensive Income & Other | -0.04 | 0.16 | 0.57 | -0.04 | -0.06 | 0.84 |
Shareholders' Equity | -11.07 | -10.06 | -7.88 | -7.86 | -2.92 | -2.59 |
Total Liabilities & Equity | 0.09 | 0.11 | 0.11 | 0.11 | 0.26 | 0.26 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Total Debt | 7.21 | 6.63 | 5.55 | 5.62 | 1.63 | 1.21 |
Net Cash (Debt) | -7.2 | -6.61 | -5.54 | -5.61 | -1.6 | -1.1 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.22 | -0.20 | -0.19 | -0.21 | -0.08 | -0.06 |
Filing Date Shares Outstanding | 36.04 | 34.46 | 31.89 | 26.41 | 23.01 | 19.38 |
Total Common Shares Outstanding | 36.04 | 34.46 | 31.89 | 26.41 | 23.01 | 19.38 |
Working Capital | -11.11 | -10.04 | -2.43 | -2.58 | -2.86 | -2.53 |
Book Value Per Share | -0.31 | -0.29 | -0.25 | -0.30 | -0.13 | -0.13 |
Tangible Book Value | -11.07 | -10.06 | -7.88 | -7.86 | -2.92 | -2.59 |
Tangible Book Value Per Share | -0.31 | -0.29 | -0.25 | -0.30 | -0.13 | -0.13 |
Machinery | 0.02 | 0.02 | 0.02 | 0.02 | - | - |
Construction In Progress | 0.03 | 0.03 | - | - | - | - |